A Summary of the Endocrine Society Clinical Practice Guidelines on Congenital Adrenal Hyperplasia due to Steroid 21-Hydroxylase Deficiency
Year: 2010
Type: article
Abstract: Steroid 21-hydroxylase deficiency accounts for about 95% of cases of congenital adrenal hyperplasia (CAH). Newborns are currently being screened for the classical forms of this disease throughout the United States and in 12 other countries. As such, it seems important to develop the best practice guidelines for treating not only infants and children, but affected adults as well. This report gives a brief overview of the most recent expert opinion and clinical practice guidelines for CAH as formulated by The Endocrine Society Task Force.
DOI: 10.1155/2010/494173
Institutions: Hofstra University, Cohen Children's Medical Center, Cedars-Sinai Medical Center, University of California, San Francisco, University of Turin, Columbia University, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health Clinical Center, New York State Psychiatric Institute, Mayo Clinic, Morgan Stanley Children's Hospital, Karolinska Institutet, The University of Texas Southwestern Medical Center
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $2,790
OpenAlex ID: W2074822469